May 9, 2024 — The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM).

May 8, 2024 —  The US Food and Drug Administration (FDA) is alerting health care providers and facilities about our continued safety and quality concerns with the following Getinge/Maquet cardiovascular medical devices:

May 8, 2024 — 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for the AltaValve System, a transcatheter mitral valve replacement (TMVR) device.

May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine scientists at 

May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve therapies from studies presented at the recent Society for Cardiovascular Angiography & Interventions 2024 Scientific Sessions, SCAI 2024, held May 2-4 in Long Beach, CA.

May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens Neuroimaging and Informatics Institute (

May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now